Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Peter Impey

Virgo Health takes up new apprenticeship scheme

The programme aims to provide a practical alternative to university education

- PMLiVE

Kane & Finkel announces new European director

John Flaherty will handle pan-European clients for the healthcare comms agency

- PMLiVE

GSK discontinues development of Anacor antibiotic

Patients developed resistance to compound during trial

- PMLiVE

AZ pays $273m for Ardelyx renal disease drug

Phase II candidate could tackle fluid overload in kidney and heart disorders

- PMLiVE

Takeda pays $60m for vaccine company LigoCyte

Gains first-in-class norovirus candidate and new vaccine platform

- PMLiVE

Massive crackdown on online pharmacies nets fake drugs

Global agencies shut down 18,000 websites and seize medicines worth $10.5m

- PMLiVE

Less than half of UK healthcare professionals use mobile apps for work

Secondary care use higher than in primary care, according to Cegedim Strategic Data study

- PMLiVE

Louise Tamblin returns to Kantar Health as group director

Moves from Strata Research

Shionogi: an expanding commercial focus

PMLiVE’s new emerging companies series starts with a Japanese firm that’s increasing its European footprint

Pharma Comes Out of the Branding Dark Ages

Isn't it high time that the pharma industry takes branding seriously rather than leaving it purely to their portfolio powerhouses?

Janssen adds Astellas JAK inhibitor to its immunology portfolio

Licenses oral rheumatoid arthritis and psoriasis candidate ASP015K

New data backs Pfizer’s Eliquis in atrial fibrillation

Findings bode well for the drug's commercial prospects

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links